THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net


S U M M A R Y


DIARY: October 11, 2005 02:51 PM Tuesday; Rod Welch

Doctor Bailey discusses mastectomy for palliation of secondary IBC.

1...Summary/Objective
2...Disease-free Status NED Purpose Mastectomy Reduce Risk Relapse
3...Purpose Wide Area Mastectomy Reduce Risk Relapse Not Palliation
4...Mastectomy Purpose Reduce Risk Relapse with Wide Area Not Palliation
5...Palliation for Disease-free Patient Cure Purpose Very Wide Mastectomy
....Mastectomy IBC Relapse Chemotherapy Reduced Effectiveness
....Brest Removal Mastectomy Surgery Risks Recovery IBC Relapse
....Blood Vessels Removed Mastectomy Reduces Chemotherapy Effectiveness


..............
Click here to comment!

CONTACTS 
0201 - Medical Offices Lisa Bailey                                                                                                                                        O-00000850 0101
020101 - Ms. Lisa Bailey, MD                                                                                                                                              O-00000850 0101
020103 - Executive Office                                                                                                                                                 O-00000850 0101

SUBJECTS
Palliation Mastectomy Surgery May Reduce Palliation Increase Risk IB

0903 -
0903 -    ..
0904 - Summary/Objective
0905 -
090501 - Follow up ref SDS 44 0000. ref SDS 36 0000.
090502 -
090503 -
090504 -
090505 -
090507 -  ..
0906 -
0907 -
0908 - Progress
0909 -
090901 - Disease-free Status NED Purpose Mastectomy Reduce Risk Relapse
090902 - Purpose Wide Area Mastectomy Reduce Risk Relapse Not Palliation
090903 - Mastectomy Purpose Reduce Risk Relapse with Wide Area Not Palliation
090904 - Palliation for Disease-free Patient Cure Purpose Very Wide Mastectomy
090905 -
090906 - Doctor Bailey called this afternoon and discussed recent developments
090907 - presented in a letter yesterday on 051010, ref SDS 44 X93F, and, also,
090908 - discussed with Doctor Grissom yesterday. ref SDS 44 GW4I
090909 -
090910 - Submitted ref DIT 1 0001 to Doctor Bailey confirming telecon....
090912 -         ..
090913 -    3.  Thanks for your call this afternoon, and for taking time
090914 -        between surgeries to comment on Millie's progress, responding
090915 -        to the letter to you yesterday (see below). ref DIT 1 0001
090917 -         ..
090918 -    4.  You indicated today that there is no evident basis for
090919 -        "palliative" mastectomy surgery in Millie's case, as called out
090920 -        by the primary care physician... in a meeting on 051007.  The
090921 -        record on this meeting has not yet been posted; however,
090922 -        yesterday Millie got a copy of the Doctor's notes in connection
090923 -        with filing a disability claim. ref DIT 1 G66W [Primary care
090924 -        physician] says in part...
090926 -             ..
090927 -            "She was seen by the plastic surgery and the decision was
090928 -            that reconstruction would add no value to our current
090929 -            palliative strategy." ref SDS 45 SM6M
090931 -         ..
090932 -    5.  Setting aside inaccuracy of the doctor's expression, the above
090933 -        sentence is the total record from the doctor on "palliative
090934 -        surgery."  During a meeting on 050913, [primary care physician]
090935 -        gave the name of another doctor at Kaiser in whom he seems to
090936 -        place great reliance for treating IBC.  He may have had
090937 -        conversations which are not entered in the record. ref DIT 1
090938 -        G68P
090940 -         ..
090941 -    6.  "Palliative strategy" for mastectomy surgery was mentioned for
090942 -        the first and only time  during the meeting last Friday, on
090943 -        051007.  Previously, on 050913 the doctor was adamant that
090944 -        mastectomy was required to save the patient's life, which seems
090945 -        to aim higher than palliation.  In any event, as you note, the
090946 -        doctor has a strong commitment to Millie having surgery.
090947 -        ref DIT 1 J687
090949 -         ..
090950 -    7.  You indicated in our call that treatment for primary IBC is
090951 -        chemo to reduce inflammation, then surgery to remove the tumor
090952 -        that causes IBC, and then more chemo and finally radiation.
090953 -        You further noted that in Millie's case of secondary IBC, where
090954 -        the tumor has been previously removed, and where the breast has
090955 -        been radiated, then there is no purpose for a standard
090956 -        mastectomy.  You indicated that if a mastectomy were to be
090957 -        performed, then the only reasonable objective is to try
090958 -        removing previously infected skin that may retain remnants of
090959 -        disease in the lymphatics which is not evident by observing the
090960 -        skin, and so does not show up from testing.  The primary care
090961 -        physician cited this concern on 051007 about microscopic cancer
090962 -        cells that could recur in connection with a "palliative
090963 -        strategy." ref SDS 43 I482  You noted today, that to remove
090964 -        only a portion of previously infected skin, as occurs with a
090965 -        standard mastectomy, has no value in reducing risk of
090966 -        recurrence. ref DIT 1 G69U
090967 -
090968 -
090969 -
0910 -

SUBJECTS
Palliation Fails Mastectomy Surgery Removes Blood Vessels Capillarie

2603 -
260401 -     ..
260402 -    Mastectomy IBC Relapse Chemotherapy Reduced Effectiveness
260403 -    Brest Removal Mastectomy Surgery Risks Recovery IBC Relapse
260404 -    Blood Vessels Removed Mastectomy Reduces Chemotherapy Effectiveness
260405 -
260406 -
260407 -    8.  You further advised that removing breast mass with surgery
260408 -        would likely frustrate aims for palliation presented on 051007,
260409 -        ref SDS 43 6A4N, by actually accelerating disease, if IBC
260410 -        relapse occurs, because there will be fewer blood vessels,
260411 -        veins, and capillaries to service infected skin with systemic
260412 -        treatment, ref DIT 1 XS4L, and perhaps with the body's immune
260413 -        system (although we did not discuss the immune system),
260414 -        reflecting Doctor Smith's analysis at Kaiser on 050928.
260415 -        ref SDS 41 248I
260417 -  ..
260418 - This scenario of mastectomy removing blood vessels and preventing
260419 - delivery of treatment to infected tissue may compound concerns about
260420 - pockets of resistance to chemotherapy presented by the primary care
260421 - physician on 050311. ref SDS 11 PA4N  This would increase resistance
260422 - to treatment when disease progresses through cancer mutation, cited by
260423 - the primary care physician on 030606. ref SDS 2 N27L  Doctor Benz
260424 - made a similar point about disease progerssing that requires changing
260425 - treatment in a 2nd opinion received on 041117.
260426 -
260427 -            [On 051012 opportunities and risks of mastectomy surgery
260428 -            following Kaiser's requirements for Time Out to perform due
260429 -            diligence, ref SDS 46 IH4P; risk of slow recovery from IBC
260430 -            relapse due to loss of blood vessels for delivering
260431 -            chemotherapy treatment cited. ref SDS 46 IC37
260433 -             ..
260434 -            [On 051018 denial overlooks due diligence "Time Out"
260435 -            analysis, ref SDS 47 145G, of future requirements for blood
260436 -            vessels to deliver treatment in the event of relapse after
260437 -            surgery. ref SDS 47 687Y
260439 -             ..
260440 -            [On 051027 surgeon reports having stretched skin and tissue
260441 -            sufficiently for standard closure of a wider than normal
260442 -            mastectomy, and this maintains sufficient blood vessel and
260443 -            related body mass for delivering nutrients and treatment,
260444 -            if necessary, for normal healing of the surgical wound, and
260445 -            in the event of IBC relapse. ref SDS 48 QY8K
260447 -             ..
260448 -            [On 060808 IBC relapse disease progresses with treatment
260449 -            that previously was effective; scenario #2 review meeting
260450 -            consider changing chemotherapy agent. ref SDS 49 HT5K
260452 -             ..
260453 -            [On 060821 2nd opinion Doctor Benz ask about expectations
260454 -            for fast recovery tempered by mastectomy surgery that
260455 -            reduces effectiveness of chemotherapy treatment.
260456 -            ref SDS 50 NN3H
260458 -             ..
260459 -            [On 060922 analysis of slow recovery with same chemotherapy
260460 -            treatment following IBC relapse, ref SDS 51 9E6L, cites
260461 -            Doctor Bailey's anlaysis on the impact of diminished
260462 -            capacity for blood vessels. ref SDS 51 ML3I
260464 -             ..
260465 -            [On 061110 doctor reports IBC rash on left breast area is
260466 -            "stable," ref SDS 53 ZL5W, indicating recovery is very
260467 -            slow, because on 051021 blood vessels were removed from the
260468 -            treatment area by mastectomy surgery, per analysis of
260469 -            expectations on 060929. ref SDS 52 EH3F
260471 -         ..
260472 -    9.  Finally, you commented that following surgery, or if Millie
260473 -        elects not to have surgery, if the skin biopsies tomorrow are
260474 -        positive, and further if she has surgery and the pathology
260475 -        finds no remnants of cancer, then this would present a
260476 -        favorable test result that could support ending chemotherapy
260477 -        treatments, scaling treatments back, or changing to a less
260478 -        debilitating regimen.  I know Millie will be pleased to hear
260479 -        this. ref DIT 1 G66P
260481 -         ..
260482 -   10.  Maybe this is a basis for a mastectomy simply to test the
260483 -        underlying tissue more rigorously, although previously on
260484 -        040419 a punch biopsy into the breast identified IBC, and so
260485 -        possibly this less invasive procedure might be more
260486 -        appropriate.  In any case, the train seems to be moving toward
260487 -        mastectomy.  I will suggest that Mil ask Kaiser to complete its
260488 -        standard "Time Out" pre-surgery work up to explain the purpose
260489 -        of the procedure, define "success", and list prior cases of
260490 -        secondary IBC that have been treated successfully with the
260491 -        proposed surgery. ref DIT 1 G66Y
260492 -
260493 -             [On 051015 Millie decided not to ask Kaiser to perform
260494 -             required "Time Out" procedures for risk management to
260495 -             verify surgery offers the best course of treatment for
260496 -             Millie.
260498 -         ..
260499 -   11.  No need to respond, unless I am way off on representing your
260500 -        views.  By copy letting Millie know of our discussion.
260501 -        ref DIT 1 PQPX
260503 -         ..
260504 -   12.  Thanks again for taking time between surgeries for this
260505 -        consultation. ref DIT 1 G74T
260506 -
260507 -
260508 -
260509 -
260510 -
260511 -
260512 -
260513 -
260514 -
260515 -
260516 -
2606 -
Distribution. . . . See "CONTACTS"
































>